Navigation Links
Stenting, Surgery Appear Comparable for Opening Neck Artery
Date:2/1/2012

WEDNESDAY, Feb. 1 (HealthDay News) -- To open a clogged neck artery, a surgeon has two options: either insert a metal stent to keep blood flowing or perform surgery. A new study finds that both approaches will likely keep the arteries clear for at least two years and help prevent stroke.

"Unlike bare metal stents placed in coronary [heart] arteries, where re-blockage occurs about 20 percent of the time, we found the re-blockage rates in the carotid artery were quite small," said study lead author Dr. Brajesh K. Lal, associate professor of vascular surgery at the University of Maryland School of Medicine in Baltimore, in a statement provided by the American Stroke Association.

"Patients and physicians can be reassured that both procedures are durable and that re-blockage rates are equivalent, so they can use different criteria to determine which procedure is right for a patient," he added.

The study was funded by the U.S. National Institute of Neurological Disorders and Stroke, and by stent maker Abbott Vascular Solutions.

Clogs in the carotid arteries -- the two large blood vessels in the neck -- cause about 10 percent of strokes. The study looked at about 2,200 patients with a partially blocked neck artery. About half the patients received a stents in the artery, which is a minimally invasive procedure, and about half underwent an artery-opening surgery.

Over two years, the researchers found that the arteries narrowed again in close to 6 percent of both groups of patients. The arteries became entirely blocked less than 1 percent of the time in both groups.

Patients whose arteries narrowed again faced a four-fold increase in their risk of stroke.

The research into these patients will continue so physicians can see what happens over a 10-year period.

Dr. Brahmajee K. Nallamothu, an associate professor of internal medicine at the University of Michigan Health System, who's familiar with the findings, said the research is valuable.

"First, it supports the durability of carotid stenting over time, and provides additional evidence for this minimally invasive treatment option," he said. "Second, it suggests a link between the recurrence of blockages and future strokes. This is an interesting observation, which has potential implications for how we manage patients who develop recurrent narrowing in their carotid artery."

Nallamothu said patients should almost always get to decide which strategy they prefer. Carotid stenting is a bit more expensive than surgery, he noted, and "side effects are the big issue. Carotid stenting appears to lower the risks of heart attacks relative to (surgery) around the time of the procedure, while the reverse is true in regards to the risk of stroke," he added.

The study was scheduled for release Wednesday at the American Stroke Association conference in New Orleans.

Research presented at meetings should be considered preliminary until published in a peer-reviewed medical journal.

More information

To learn about carotid artery disease, visit the U.S. National Institutes of Health.

-- Randy Dotinga

SOURCES: Brahmajee K. Nallamothu, M.D., associate professor of internal medicine, University of Michigan Health System, Ann Arbor; American Stroke Association, International Stroke Conference 2012, New Orleans, Feb. 1, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Repeated Weight-Loss Surgery Carries Added Risks
2. The New Liposuction Technique Means No Surgery or Suction
3. Research validates surgery alone offers reasonable overall survival for stage I SCLC
4. "New Cosmetic Surgery" Journalism Prize
5. Abington Memorial Hospital Welcomes Vakil to Orthopaedic Surgery Division
6. Drug for advanced kidney cancer shrinks tumors prior to surgery
7. Abington Memorial Hospital Earns Two Designations: Blue Distinction Center for Spine Surgery(SM) and Blue Distinction Center for Knee and Hip Replacement(SM)
8. New endoscopic treatment may spare Barretts esophagus patients from surgery
9. Pittsburgh Neurosurgeons Explore Use of Drug that Illuminates Brain Tumor Cells To Guide Surgery
10. Surgery Alone May Thwart Stage 1 Lung Cancer
11. Comparison shows robot-assisted option offers advantages for kidney surgery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stenting, Surgery Appear Comparable for Opening Neck Artery 
(Date:2/10/2016)... ... 10, 2016 , ... Early this week, Team Iconic at J. Walter Thompson ... as the first global confectionery brand sourced from 100% sustainable cocoa. , The Nestlé ... their product, through activities that focus on better farming, better lives and better cocoa. ...
(Date:2/10/2016)... ... ... As part of its ongoing series of aquatic therapy related webinars, HydroWorx ... dynamic expert and thoughtful presentation to give attendees a better sense of how to ... free to attend, but registration is required. , Rehabilitation of Offensive Lineman ...
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency ... find. Unfortunately, this can leave patients with dental emergencies at risk of losing a ... offering emergency dental care. , Common dental emergencies include:, , ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... will bring together more than 200 of the country’s top healthcare executives to ... , “The true benefit of the Forum is the provider-centric perspective, experience, expertise ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: ... winner and inspirational speaker Jan Fox will serve as keynote speaker at the ... provide participants with tools to more effectively communicate with their own organizational staff ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 10, 2016  Rich Pharmaceuticals, Inc. (OTC Markets: RCHA) ... reverse split of its issued and outstanding shares of ... Thursday, February 11, 2016. The Company,s common stock will ... 76303T308 and temporary ticker symbol "RCHAD". After 20 trading ... ticker symbol (RCHA).  --> ...
(Date:2/10/2016)... 2016  Oxis International Inc. (OTC/QB: OXIS) announced today ... as a "clinical trial triumph" after one of the ... cancer remission. Daniel Vallera , a ... Center. --> Daniel Vallera , a ... Center. --> An article on the ...
(Date:2/10/2016)... Feb. 10, 2016  The ALS Association, in partnership with ... Challenge to generate a biomarker to track TDP43 aggregation. The ... to a $1 million investment. --> ... that affects nerve cells in the brain and the spinal ... and control muscle movement, which often leads to total paralysis ...
Breaking Medicine Technology: